Second, the CCK-8 assay results indicated that knocking down NEDD4L dose-dependently attenuated the anti-MM efficacy of Bor in ARP-1 and RPMI8226 cells (Fig. 3C). Here, NEDD4L is linked to Miyoshi myopathy.